Concepedia

Josef Mayr

JM

Statistics

Publications

10

Citations

517

H-Index

10

Active since

2013

Affiliations

University of Vienna(Current)

Comprehensive Cancer Center Vienna

Medical University of Vienna

Czech Academy of Sciences, Institute of Analytical Chemistry

Institute of Inorganic Chemistry of the Slovak Academy of Sciences

Josef Mayr is an author at University of Vienna specializing in medicinal chemistry, drug delivery, and cancer pharmacology.

Publications per year

2013–2025

10

Publications

10

An albumin-based tumor-targeted oxaliplatin prodrug with distinctly improved anticancer activity in vivo

Josef Mayr, Petra Heffeter, Diana Groza et al. · Chemical Science · 2016 · 130 citations · Full text

Medicine, Oncology, Pharmacology +17

Maleimide-functionalised platinum(iv) complexes as a synthetic platform for targeted drug delivery

Verena Pichler, Josef Mayr, Petra Heffeter et al. · Chemical Communications · 2013 · 90 citations

Pharmacy, Medicinal Chemistry, Pharmaceutics +17

Improving the Stability of Maleimide–Thiol Conjugation for Drug Targeting

Marianne Lahnsteiner, Alexander Kastner, Josef Mayr et al. · Chemistry - A European Journal · 2020 · 80 citations · Full text

Pharmacy, Biochemistry, Medicinal Chemistry +11

A Dogma in Doubt: Hydrolysis of Equatorial Ligands of Pt<sup>IV</sup> Complexes under Physiological Conditions

Alexander Kastner, Isabella Poetsch, Josef Mayr et al. · Angewandte Chemie International Edition · 2019 · 65 citations · Full text

Natural Sciences, Biochemistry, Chemistry +12

Albumin-targeting of an oxaliplatin-releasing platinum(<scp>iv</scp>) prodrug results in pronounced anticancer activity due to endocytotic drug uptake <i>in vivo</i>

Hemma Schueffl, Sarah Theiner, Gerrit Hermann et al. · Chemical Science · 2021 · 41 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

1–5 of 10